Medical implant failure is generally the result of either:

• Poor bone growth between the implant surface and surrounding tissue (loosening of the implant)
• Bacterial infection at the surgical site

Both types of implant failure result in painful, costly, and time-consuming revision procedures for the patient and surgeon. Orlumet’s innovative surface coating technology is specifically designed to enhance the biointegration process of the implant, while at the same time reduce the probability of implant failure due to poor bone growth and infection. Drawing upon recent advances in the field of bio-nanotechnology Orlumet’s nanocomposite surface coatings are comprised of bioactive layers that can be finely tuned, allowing for the capacity to:

• Improve osseointegration by enhancing osteoblast binding and proliferation at the surface of the medical device
• Accelerate bone formation
• Prevent the formation of biofilms via cationic surface properties
• Bind antibiotics/bacteriostatic agents, growth factors, and other bioactive materials
• Control the release of antibiotics in accordance with the desired biological function

Orlumet’s coatings have a very high affinity for metallic surfaces such as titanium, polymeric surfaces, and ceramics. All materials utilized in our coatings are inherently inexpensive, and are approved for use by the FDA.